Chase AIPricingFAQs
Display currency
Loading news…

SeQure Dx

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Waltham, Massachusetts, United States Founded 2020 11-50 employees For Profit

SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies

SeQure Dx was acquired by MaxCyte in 2025.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
21
Patents
2
5 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Patents granted
2
Trademarks
5
Top patent class
Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
IT spend
$255K

Company Info

Founded
2020
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
2
News articles
14
HQ
Waltham, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Founded
Exit date
Jan 30, 2025

Signals & Scores

Heat score
Low
Trend (7d)
1.3
Trend (30d)
0
Trend (90d)
2.8

Key People at SeQure Dx

Founder & CEO
Senior Vice President, Assay Research & Development
21
professional contacts at SeQure Dx
Contact execs at SeQure Dx

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to SeQure Dx

Loading news…

FAQs about SeQure Dx

People who checked this page also checked these

Browse the full Acquirezy directory.
SeQure Dx - Company Profile, Full Acquisitions List, Funding and Investments